181
Views
7
CrossRef citations to date
0
Altmetric
Articles

Reduced penicillin susceptibility of group B Streptococcus: an assessment of emergence in Grampian, Scotland

, &

References

  • Huang PY, Lee MH, Yang CC, et al. Group B streptococcal bacteraemia in non-pregnant adults. J. Microbiol. Immunol. Infect. 2006;39:237–241.
  • Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 1998;11:497–513.
  • Wang Y-H, Chen H-M, Yang Y-H, et al. Clinical and microbiological characteristics of recurrent group B streptococcal infection among non-pregnant adults. Int. J. Infect. Dis. 2014;26:140–145.10.1016/j.ijid.2014.05.026
  • Farley MM. Group B streptococcal disease in nonpregnant adults. Clin. Infect. Dis. 2001;33:556–561.10.1086/cid.2001.33.issue-4
  • Skoff TH, Farley MM, Petit S, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults 1990–2007. Clin. Infect. Dis. 2009;49:85–92.10.1086/599185
  • Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 2005;41:839–847.
  • Centres for Disease Control and Prevention. Prevention of prenatal group B streptococcal disease. MMWR Morb Mortal Wkly Rep. 2002;51:1–22.
  • Clinical and laboratory standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-Fourth informational supplement M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.
  • Kimura K, Suzuki S, Wachino J, et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 2008;52:2890–2897.10.1128/AAC.00185-08
  • Dahesh S, Hensler ME, Van Sorge NM, et al. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob. Agents Chemother. 2008;52:2915–2918.10.1128/AAC.00461-08
  • Murayama SY, Seki C, Sakata H, et al. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob. Agents Chemother. 2009;53:2650–2653.10.1128/AAC.01716-08
  • Persson E, Berg S, Bergseng H, et al. Antimicrobial susceptibility of invasive group B streptococcal isolates from south-west Sweden 1988–2001. Scand. J. Infect. Dis. 2008;40:308–313.10.1080/00365540701678702
  • Gaudreau C, Lecours R, Ismail J, et al. Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone. J. Antimicrob. Chemother. 2009;65:594–595.
  • Longtin J, Vermeiren C, Shahinas D, et al. Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy. Antimicrob. Agents Chemother. 2011;55:2983–2985.10.1128/AAC.01243-10
  • Kimura K, Wachino J, Kurokawa H, et al. Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility. J. Clin. Microbiol. 2009;47:4154–4157.10.1128/JCM.02063-08
  • Public Health England. Voluntary surveillance of pyogenic and non-pyogenic streptococcal bacteraemia in England, Wales and Northern Ireland: 2012. HPR; 2013;7(46).
  • Public Health England. Voluntary surveillance of pyogenic and non-pyogenic streptococcal bacteraemia in England, Wales and Northern Ireland: 2014. HPR. 2015;9(41).
  • Centres for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, 2010. MMWR 2010; 59 (No. RR-10).
  • Kasahara K, Baltus AJ, Lee SH, et al. Prevalence of non-penicillin-susceptible group B streptococcus in Philadelphia and specificity of penicillin resistance screening methods. J. Clin. Microbiol. 2010;48:1468–1469.10.1128/JCM.02296-09
  • Wang P, Ma Z, Tong J, et al. Serotype distribution, antimicrobial resistance, and molecular characterization of invasive group B streptococcus isolates recovered from Chinese neonates. Int. J. Infect. Dis. 2015;37:115–118.10.1016/j.ijid.2015.06.019

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.